Literature DB >> 17055125

Immunization with recombinant bovine but not mouse prion protein delays the onset of disease in mice inoculated with a mouse-adapted prion.

Daisuke Ishibashi1, Hitoki Yamanaka, Naohiro Yamaguchi, Daisuke Yoshikawa, Risa Nakamura, Nobuhiko Okimura, Yoshitaka Yamaguchi, Kazuto Shigematsu, Shigeru Katamine, Suehiro Sakaguchi.   

Abstract

Host tolerance to endogenous prion protein (PrP) has hampered the development of prion vaccines as PrP is a major component of prions. Indeed, we show that immunization of mice with mouse recombinant PrP elicited no prophylactic effect against a mouse-adapted prion. However, interestingly, mice immunized with recombinant bovine PrP developed the disease significantly later than non-immunized mice after inoculation of a mouse prion. Sheep recombinant PrP exhibited variable prophylactic effects. Mouse recombinant PrP stimulated only very weak antibody responses. In contrast, bovine recombinant PrP was higher immunogenic and produced variable amounts of anti-mouse PrP autoantibodies. Sheep recombinant PrP was also immunogenic but produced more variable amounts of anti-PrP autoantibodies. These results might open a new way for development of prion vaccines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055125     DOI: 10.1016/j.vaccine.2006.09.078

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Direct evidence of generation and accumulation of β-sheet-rich prion protein in scrapie-infected neuroblastoma cells with human IgG1 antibody specific for β-form prion protein.

Authors:  Toshiya Kubota; Yuta Hamazoe; Shuhei Hashiguchi; Daisuke Ishibashi; Kazuyuki Akasaka; Noriyuki Nishida; Shigeru Katamine; Suehiro Sakaguchi; Ryota Kuroki; Toshihiro Nakashima; Kazuhisa Sugimura
Journal:  J Biol Chem       Date:  2012-02-22       Impact factor: 5.157

2.  Mucosal immunization with an attenuated Salmonella vaccine partially protects white-tailed deer from chronic wasting disease.

Authors:  Fernando Goñi; Candace K Mathiason; Lucia Yim; Kinlung Wong; Jeanette Hayes-Klug; Amy Nalls; Daniel Peyser; Veronica Estevez; Nathaniel Denkers; Jinfeng Xu; David A Osborn; Karl V Miller; Robert J Warren; David R Brown; Jose A Chabalgoity; Edward A Hoover; Thomas Wisniewski
Journal:  Vaccine       Date:  2014-12-21       Impact factor: 3.641

Review 3.  Immunotherapy in prion disease.

Authors:  Yvonne Roettger; Yansheng Du; Michael Bacher; Inga Zerr; Richard Dodel; Jan-Philipp Bach
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

4.  High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice.

Authors:  F Goñi; F Prelli; F Schreiber; H Scholtzova; E Chung; R Kascsak; D R Brown; E M Sigurdsson; J A Chabalgoity; T Wisniewski
Journal:  Neuroscience       Date:  2008-03-06       Impact factor: 3.590

5.  Toxic effects of intracerebral PrP antibody administration during the course of BSE infection in mice.

Authors:  Maxime Lefebvre-Roque; Elisabeth Kremmer; Sabine Gilch; Wen-Quan Zou; Cécile Féraudet; Chantal Mourton Gilles; Nicole Salès; Jacques Grassi; Pierluigi Gambetti; Thierry Baron; Hermann Schätzl; Corinne Ida Lasmézas
Journal:  Prion       Date:  2007-07-15       Impact factor: 3.931

Review 6.  The immunobiology of prion diseases.

Authors:  Adriano Aguzzi; Mario Nuvolone; Caihong Zhu
Journal:  Nat Rev Immunol       Date:  2013-11-05       Impact factor: 53.106

7.  Detection and control of prion diseases in food animals.

Authors:  Peter Hedlin; Ryan Taschuk; Andrew Potter; Philip Griebel; Scott Napper
Journal:  ISRN Vet Sci       Date:  2012-02-29

8.  Immunization with recombinant prion protein leads to partial protection in a murine model of TSEs through a novel mechanism.

Authors:  Konstantinos Xanthopoulos; Rosa Lagoudaki; Anastasia Kontana; Christos Kyratsous; Christos Panagiotidis; Nikolaos Grigoriadis; Minas Yiangou; Theodoros Sklaviadis
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

9.  Dendritic cell-mediated-immunization with xenogenic PrP and adenoviral vectors breaks tolerance and prolongs mice survival against experimental scrapie.

Authors:  Martine Bruley Rosset; Antoine Sacquin; Sylvie Lecollinet; Thomas Chaigneau; Micheline Adam; François Crespeau; Marc Eloit
Journal:  PLoS One       Date:  2009-03-19       Impact factor: 3.240

Review 10.  Recombinant PrP and Its Contribution to Research on Transmissible Spongiform Encephalopathies.

Authors:  Jorge M Charco; Hasier Eraña; Vanessa Venegas; Sandra García-Martínez; Rafael López-Moreno; Ezequiel González-Miranda; Miguel Ángel Pérez-Castro; Joaquín Castilla
Journal:  Pathogens       Date:  2017-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.